WORLAND STEPHEN T (President and Chief Executive) received a stock award from EFFECTOR THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/17/2024ACC: 0000950170-24-061593
DirectorOfficer· President and Chief Executive
Since Aug 2021
+1.81K
Net shares
Net buyer
$3.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1.81K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.81K
Price / share
$1.68
Trade value
$3.04K
% of position
16.9%
5/15/2024
10.69K→12.49K
Total
Net shares
+1.81K
Net value
$3.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2024 | A · Award | +1.81K | $1.68 | $3.04K | 16.9% | 10.69K | 12.49K |
| Total | +1.81K | $3.04K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned22.49K
Total
22.49K indirect22.49K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 22.49K | Indirect |
| Total | 22.49K | 22.49K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported